Looking for a District of Columbia Gleevec lawyer? Get in touch with one of our District of Columbia Gleevec lawyers now.
Gleevec - News Articles
-
Jun 5, 2007
United Press International -
CHICAGO, June 5 (UPI) -- Adding Gleevec after surgery for gastrointestinal stromal tumors prevents return of cancer in more than 90 percent of patients, say U.S. doctors. In a trial sponsored by the National Cancer Institute, 644 patients who were diagnosed with ... -
Jun 6, 2007
MedPage Today, NJ -
CHICAGO, June 6 -- Imatinib (Gleevec) after curative surgery for gastrointestinal stromal tumors resulted in a 90% recurrence-free survival after two years. ... -
Tuesday, May 29, 2007
MSN Money -
Pfizer: Follow up Inside today's Oncology data press release the co also announced the expansion of the clinical trial program evaluating the efficacy and safety of sunitinib malate in the treatment of breast cancer. The co has initiated three additional phase III trials ... -
Tuesday, May 29, 2007
StreetInsider.com (subscription), MI -
Pfizer (NYSE: PFE) has results showing potential across numerous types of cancer, such as melanoma, thyroid, liver, non-small cell lung (NSCLC), colorectal (CRC) and renal cell carcinoma (RCC) - a type of advanced kidney cancer - will be presented next ... -
Tuesday, May 29, 2007
PharmaLive.com (press release), PA -
NEW YORK--(BUSINESS WIRE)--May 29, 2007 - Pfizer said today that results showing potential across numerous types of cancer, such as melanoma, thyroid, liver, non-small cell lung(NSCLC), colorectal (CRC) and renal cell carcinoma (RCC) - a type ofadvanced kidney cancer - will ... -
Wednesday, May 30, 2007
Genetic Engineering News (press release), NY -
INNOVIVE Pharmaceuticals, Inc. (OTCBB: IVPH) today announced that interim data from a Phase I trial of INNO-406, an orally bioavailable dual Bcr-Abl and acute myelogenous leukemia, respectively. For additional informationvisit www.innovivepharma.com. Gleevec(R) is a registered trademark of Novartis PharmaceuticalsCorporation. back ... -
May 24, 2007
Marin Independent-Journal, CA -
The medication Migden is currently taking - the designer drug Gleevec - blocks the rapid growth of white blood cells by inhibiting the enzyme. "It's been breathtakingly effective in controlling the disease," said Dr. David Lakes, chief of oncology at Kaiser Permanente Medical Center ... -
May 25, 2007
Pittsburgh Tribune-Review, PA -
Background: Duensing and her colleagues are examining the mechanisms of actino of Gleevec, a treatment for gastrointestinal stromal tumors, or GISTs. These tumors occur in the gastrointestinal tract and are particularly difficult to treat successfully over time. Although the Gleevec ... -
May 23, 2007
Cancer Consultants (press release), TN -
Researchers associated with the CA 180-005 ‘START A’ phase II study reported outcomes of patients with Gleevec-intolerant or resistant patients in the accelerated phase (AP) of CML treated with Sprycel (dasatinib).The details of this study appeared in the May 16, 2007 ... -
May 18, 2007
Cancerpage.com, GA -
NEW YORK MAY 18, 2007 (Reuters Health) - Without additional chemotherapy, imatinib along with steroid treatment may induce complete remission and prolong survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia (ALL), Italian researchers report in the May 1st issue ...
-
May 14, 2007
WebWire (press release), GA -
Dr. Duensing and her colleagues are examining the mechanisms of action of Gleevec, a treatment for GIST that, although initially effective, does not stop tumors from growing long-term and does not work in about 15 percent of patients.A large number of patients with ... -
May 2, 2007
News-Medical.net, Australia -
A new study highlighted on the cover of this week's issue of Cancer Research finds that the anti-cancer drug Gleevec, is far more effective against a drug-resistant strain of cancer when the drug wraps the target with a molecular bandage that seals out water from ... -
May 14, 2007
Medscape (subscription) -
On March 8, Health Canada approved 2 new indications for imatinib mesylate (Gleevec tablets, Novartis Pharmaceuticals Canada, Inc), allowing its use as a ... -
May 3, 2007
Scoop.co.nz, New Zealand -
“Sutent is the first and only agent to be approved in the second line treatment of GIST following treatment with imatinib, and it is good that New Zealanders will have access to it,” DrKetelbey said.“Each year around 242 New Zealanderssuffer from advanced RCC, and approximately 52 ... -
May 6, 2007
Medical News Today (press release), UK -
Treatment with imatinib causes clinical remissions in most patients with chronic myeloid leukemia, but relapses are common and the cancer can become resistant to the drug. The oncogene, BCR-ABL, is the cause of chronic myeloid leukemia. Researchers have hypothesized that the ... -
May 2, 2007
Cancerpage.com, GA -
NEW YORK MAY 01, 2007 (Reuters Health) - The kinase inhibitor dasatinib induces complete responses in patients with imatinib-resistant or imatinib-intolerant (blast crisis) CML and will undoubtedly affect the treatment paradigm for CML."SOURCE:Blood 2007;109:3207-3213. ... -
May 4, 2007
Forbes, NY -
Vasella also hopes to come up with another Gleevec ( see FORBES cover story, Feb. 5, 2001). The lifesaving leukemia pill now is Novartis' second-biggest ... -
May 1, 2007
EurekAlert (press release), DC -
HOUSTON, May 1, 2007 -- A new study highlighted on the cover of this week's issue of Cancer Research finds that the anti-cancer drug Gleevec® is far more ... -
May 1, 2007
Science Daily (press release) -
Science Daily — A new study in Cancer Research finds that the anti-cancer drug Gleevec® is far more effective against a drug-resistant strain of cancer when the drug wraps the target with a molecular bandage that seals out water from a critical area. This image ... -
May 1, 2007
Cancer Consultants (press release), TN -
According to results from a large North American clinical trial, Gleevec® (imatinib mesylate) reduces the risk of a cancer recurrence following surgery in the treatment of gastrointestinal stromal tumors (GIST). The interim analyses of these results have prompted the United States National ...
Looking for a District of Columbia Gleevec lawyer? Get in touch with one of our District of Columbia Gleevec lawyers now.
Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 ... Next
These articles are related to: Gleevec Claim, Gleevec Lawsuit, Gleevec Law Suit, Gleevec Law Firm, Gleevec Lawyer, Gleevec Attorney, Gleevec Side Effects Symptoms, Gleevec Trial, Gleevec Verdict, Gleevec News, Gleevec Information, Gleevec Recall Lawyers, Gleevec Warning, Gleevec Class Action, Gleevec Prescription Drug, Gleevec Medication, Gleevec Drugs, Imatinib Claim, Imatinib Lawsuit, Imatinib Law Suit, Imatinib Law Firm, Imatinib Lawyer, Imatinib Attorney, Imatinib Side Effects Symptoms, Imatinib Trial, Imatinib Verdict, Imatinib News, Imatinib Information, Imatinib Recall Lawyers, Imatinib Warning, Imatinib Class Action, Imatinib Prescription Drug, Imatinib Medication, Imatinib Drugs
